Caricamento...
Thromboprophylaxis in a patient with COVID‐19 and severe hemophilia A on emicizumab prophylaxis
COVID‐19 can be associated with coagulopathy (CAC, COVID‐19‐associated coagulopathy) with a high prothrombotic risk based on an intense inflammatory response to viral infection leading to immunothrombosis through different procoagulant pathways. Emerging evidence suggests that the use of heparin in...
Salvato in:
| Pubblicato in: | J Thromb Haemost |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307111/ https://ncbi.nlm.nih.gov/pubmed/32526092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14954 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|